MARKER THERAPEUTICS, INC. Repayments of Convertible Debt
MARKER THERAPEUTICS, INC. (MRKR) reported Repayments of Convertible Debt of $20.00 thousand for the 179-month period ending 2014-06-30, per its 10-Q filed 2014-08-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2015-04-15
- MARKER THERAPEUTICS, INC. repayments of convertible debt for the quarter ending 2013-12-31 was $179.00K.
- MARKER THERAPEUTICS, INC. repayments of convertible debt for the quarter ending 2013-03-31 was $108.60K.
- MARKER THERAPEUTICS, INC. repayments of convertible debt for fiscal 2013 was $20.00K.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month | Repayments of Convertible Debt 173 month | Repayments of Convertible Debt 179 month |
|---|---|---|---|---|---|
| 2014-06-30 | $20.00K 10-Q · filed 2014-08-18 | ||||
| 2013-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $20.00K 10-K · filed 2015-04-15 | -$20.00K 10-Q/A · filed 2014-05-21 | ||
| 2013-09-30 | -$159.00K 10-Q · filed 2014-11-19 | ||||
| 2013-03-31 | $108.60K 10-Q/A · filed 2014-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |